Press Releases

Press Releases

February 2, 2023
Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference
January 5, 2023
Surface Oncology Announces First Patient Dosed in a Phase 1/2 Study Evaluating SRF114, a Potential Best-In-Class Anti-CCR8 Antibody, in Patients with Advanced Solid Tumors